Medicare Chronic Care Revenue for AFib | FAQ Guide

While a clinician must still interpret lab results, AI can automate the data collection phase—reminding patients of upcoming blood draws and collecting self-reported symptoms of bleeding or bruising. This significantly reduces the administrative burden on anticoagulation clinics.

AFib quality measures, such as the 'Anticoagulation Therapy for Atrial Fibrillation' measure, directly impact MIPS reimbursement. AI ensures higher compliance rates by providing consistent follow-up, which leads to better performance scores and higher Medicare incentive payments.

Yes. Time spent by clinical staff—or the AI tools they supervise—to monitor and manage a patient's treatment plan counts toward the 20-minute CCM requirement. This allows practices to scale their AFib programs without hiring additional FTEs.

When the AI identifies a pattern of non-compliance with anti-arrhythmic drugs (AADs), it flags the patient for a priority clinical review. This prevents rhythm destabilization and potential hospitalizations, which is a key goal of Medicare's value-based care initiatives.

Yes. By conducting regular, brief symptom assessments via phone, the AI can identify patients who may be experiencing 'blanking period' arrhythmias or true recurrence, allowing the electrophysiologist to adjust the care plan or schedule a cardioversion promptly.

Absolutely. Even after a successful ablation, AFib is considered a chronic condition due to the risk of recurrence and the need for ongoing stroke prevention. AI-led monitoring ensures these patients remain engaged in the practice's CCM program indefinitely.

By identifying early signs of rate-control failure or rhythm recurrence, the AI allows for outpatient medication adjustments. This proactive management keeps AFib patients out of the emergency department, which is a primary metric for Medicare's cost-efficiency ratings.

If a patient reports palpitations during an automated call, the AI uses branching logic to assess severity. If the symptoms meet specific criteria, the system can offer to transfer the patient to the office or generate an urgent task for the EP team.

Yes, our AI solution is designed to integrate with major EHRs. It pushes structured data and interaction summaries directly into the patient's chart, ensuring that all AFib-related monitoring is documented for both clinical safety and Medicare audit protection.

The platform is fully HIPAA-compliant, utilizing encrypted data transmission and multi-factor authentication for patient identification. All AFib health data, including heart rate trends and medication lists, is handled with the highest level of security.

The ROI is seen in two ways: increased revenue from higher CCM/APCM enrollment and reduced overhead. By automating the 20 minutes of monthly engagement, practices can manage 5x more AFib patients per coordinator compared to manual phone calls.

During routine calls, the AI can deliver short, targeted educational segments about the importance of anticoagulation and the signs of stroke. This consistent reinforcement improves patient health literacy and satisfies Medicare requirements for patient education.